戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cing following biochemical identification as Pasteurella.
2 glycosyltransferase proteins found in Type D Pasteurella.
3                                              Pasteurella aerogenes has been implicated in reproductiv
4 ne-associated isolates (P. dagmatis [n = 2], Pasteurella canis [n = 2], and N. canis [n = 1]) are dis
5                                              Pasteurella canis was the most common isolate of dog bit
6 ourse of inflammation following experimental Pasteurella challenge was altered in C2D recipients.
7 uld help clinicians to make the diagnosis of Pasteurella conjunctivitis in every day practice.
8                                              Pasteurella dagmatis and Neisseria canis were repeatedly
9 differences in the active sites of these two Pasteurella enzymes.
10  other members of Haemophilus-Actinobacillus-Pasteurella family, where genetic manipulation is limite
11 lycosyltransferases, EXT1 and 2, or to other Pasteurella glycosaminoglycan synthases that produce hya
12                                          The Pasteurella HA synthase enzyme, pmHAS, catalyzes the syn
13                                            A Pasteurella haemolytica A1 gene was identified from a re
14 eningococci (GBMs), Escherichia coli K1, and Pasteurella haemolytica A2.
15 nd expression vectors that replicate both in Pasteurella haemolytica and in Escherichia coli were con
16     Twenty-four matched pairs of isolates of Pasteurella haemolytica and three matched pairs of isola
17                                            A Pasteurella haemolytica cosmid clone that activates leuk
18 nd generation of chromosomal gene fusions in Pasteurella haemolytica has been devised and used to cre
19                                              Pasteurella haemolytica is an important respiratory path
20                                              Pasteurella haemolytica is the principal bacterial patho
21           Recent reports have shown that the Pasteurella haemolytica leukotoxin (LKT) and other RTX t
22 ernatant (CCS) preparations of the RTX toxin Pasteurella haemolytica leukotoxin (LKT) contained LKT a
23                               The effects of Pasteurella haemolytica leukotoxin (LKT) on the activity
24            Exposure of bovine neutrophils to Pasteurella haemolytica leukotoxin (LKT) stimulates the
25 ciation of two other RTX toxin proteins, the Pasteurella haemolytica leukotoxin (LktA) and the entero
26                   The related RTX toxin, the Pasteurella haemolytica leukotoxin structural protein (L
27            Infection of the bovine lung with Pasteurella haemolytica results in an acute respiratory
28        Leukotoxin and endotoxin derived from Pasteurella haemolytica serotype 1 are the primary virul
29                                              Pasteurella haemolytica serotype 1 is the bacterial agen
30                                              Pasteurella haemolytica serotype 1 is the bacterium most
31                                              Pasteurella haemolytica serotype A1 (bovine strain OK) w
32 ine pulmonary surfactant is bactericidal for Pasteurella haemolytica when surfactant and bacteria mix
33 ication (R-M) system of the bovine pathogen, Pasteurella haemolytica, have been identified immediatel
34                                              Pasteurella haemolytica, the causative agent of shipping
35 e protein of the bovine respiratory pathogen Pasteurella haemolytica, was cloned, and its nucleotide
36 nary tissue after respiratory infection with Pasteurella haemolytica.
37 , Haemophilus somnus, Neisseria species, and Pasteurella haemolytica.
38  had rising antibody titers against RBCV and Pasteurella haemolytica.
39 nchial epithelium after acute infection with Pasteurella haemolytica.
40 0 and 35,000 [32K and 35K, respectively]) of Pasteurella haemolytica.
41 E from Neisseria meningitidis, and LpsA from Pasteurella haemolytica.
42                                  Mannheimia (Pasteurella) haemolytica A1 produces several virulence f
43           Leukotoxin secreted by Mannheimia (Pasteurella) haemolytica binds to the intact signal pept
44     Leukotoxin (Lkt) secreted by Mannheimia (Pasteurella) haemolytica is an RTX toxin which is specif
45 bility of ruminant leukocytes to Mannheimia (Pasteurella) haemolytica leukotoxin (Lkt).
46 otoxin structural gene (lktA) of Mannheimia (Pasteurella) haemolytica was investigated by nucleotide
47  of OmpA were investigated in 31 Mannheimia (Pasteurella) haemolytica, 6 Mannheimia glucosida, and 4
48 lktC, lktB, and lktD genes in 23 Mannheimia (Pasteurella) haemolytica, 6 Mannheimia glucosida, and 4
49 eptor for leukotoxin secreted by Mannheimia (Pasteurella) haemolytica.
50 onsisting of various portions of both of the Pasteurella heparosan synthases in a single polypeptide
51 etes in the feces and increased abundance of Pasteurella in the oropharynx.
52 sma isolates or from the Acholeplasma or the Pasteurella isolates, demonstrating a high degree of spe
53  PASTEURELLA: Of the more than 17 species of Pasteurella known, Pasteurella multocida subsp. multocid
54 that the 39-kDa cross-protective protein was Pasteurella lipoprotein B, or PlpB.
55                            The leukotoxin of Pasteurella (Mannheimia) haemolytica is believed to play
56                                              Pasteurella (Mannheimia) haemolytica leukotoxin (Lkt) ca
57 ecies for known seabird pathogens, including Pasteurella multocida (avian cholera) (9.9% [6.6-14.0] i
58  The intracellularly acting protein toxin of Pasteurella multocida (PMT) causes numerous effects in c
59     Neuraminidases produced by 16 strains of Pasteurella multocida (serotypes 1 to 16) were character
60                            Here, we identify Pasteurella multocida alpha2-3-sialyltransferase M144D m
61 c nonfastidious species were as follows: for Pasteurella multocida and staphylococci tested on Muelle
62 ents were conducted with a zoonotic pathogen Pasteurella multocida and the fluoroquinolone enrofloxac
63 zae, Proteus mirabilis, Vibrio fischeri, and Pasteurella multocida are all cleaved by RNase III as pr
64      Bordetella bronchiseptica and toxigenic Pasteurella multocida are the etiologic agents of swine
65 ly potent against the Gram-negative pathogen Pasteurella multocida both in vitro and in a mouse infec
66 eir potencies against the bacterial pathogen Pasteurella multocida both in vitro and in mouse infecti
67                    The fowl cholera pathogen Pasteurella multocida Carter Type A also produces HA in
68                             The pnhA gene of Pasteurella multocida encodes PnhA, which is a member of
69 oop sequences from Enterococcus faecalis and Pasteurella multocida gamma-GCS-GS, isoforms that are in
70                                  To identify Pasteurella multocida genes that are differentially expr
71                                          The Pasteurella multocida HA synthase, pmHAS, a polymerizing
72 gmented genomic DNA from the animal pathogen Pasteurella multocida has identified a gene encoding a p
73 P]UDP products made by the purified class II Pasteurella multocida HAS were not released by adding un
74            Outer membrane proteins (OMPs) of Pasteurella multocida have various functions related to
75                                          The Pasteurella multocida heparosan synthases, PmHS1 and PmH
76                                          The Pasteurella multocida hyaluronan synthase (PmHAS) cataly
77  the literature, of ocular infections due to Pasteurella multocida include: endophtalmitis, keratitis
78                                              Pasteurella multocida is a bacterial pathogen that cause
79                                              Pasteurella multocida is a mucosal pathogen that coloniz
80                                              Pasteurella multocida is a rare cause of neonatal bacter
81                                              Pasteurella multocida is a small nonmotile gram-negative
82                                              Pasteurella multocida is a zoonotic Gram-negative cocco-
83                            As infection with Pasteurella multocida is common in rabbits, an enzyme im
84                                              Pasteurella multocida is composed of three subspecies th
85 e rapid, accurate method to detect toxigenic Pasteurella multocida is needed for improved clinical di
86        The dermatonecrotic toxin produced by Pasteurella multocida is one of the most potent mitogeni
87                                              Pasteurella multocida is the causative agent of a wide r
88                                              Pasteurella multocida isolates with enrofloxacin MIC of
89 enes encoding Haemophilus influenzae D15 and Pasteurella multocida Oma87 protective outer membrane an
90 istophilus somni, Mannheimia haemolytica and Pasteurella multocida over a wide dynamic range.
91 hase, PmCS, from the Gram-negative bacterium Pasteurella multocida polymerize the glycosaminoglycan (
92                         Toxigenic strains of Pasteurella multocida produce a 146 kDa toxin (PMT) that
93 isolates and 4 attenuated vaccine strains of Pasteurella multocida recovered from multiple avian spec
94               We present a case of fulminant Pasteurella multocida sepsis in a 66-year-old man who ha
95                    Fowl cholera is caused by Pasteurella multocida serovars A:1, A:3, and A:4.
96                                              Pasteurella multocida sialic acid aldolase (PmAldolase),
97 -ray crystal structures of a multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1) w
98 he structures of a truncated multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1),
99 ot multienzyme sialylation system containing Pasteurella multocida sialyltransferase 3 (PmST3) with i
100                                              Pasteurella multocida strains isolated from 15 pigs with
101 ntical for P. multocida subsp. multocida and Pasteurella multocida subsp. gallicida but differs from
102 e more than 17 species of Pasteurella known, Pasteurella multocida subsp. multocida and Pasteurella m
103                                              Pasteurella multocida subsp. multocida is a commensal an
104 , Pasteurella multocida subsp. multocida and Pasteurella multocida subsp. septica are among the most
105  mediates adhesion of serogroup A strains of Pasteurella multocida to elicited turkey air sac macroph
106 as assessed by exposing broth suspensions of Pasteurella multocida to perflubron for various times.
107 agonists and phospholipase C is activated by Pasteurella multocida toxin (a G(q) alpha-subunit agonis
108                           We have shown that Pasteurella multocida toxin (PMT) directly causes transi
109                                              Pasteurella multocida toxin (PMT) has been hypothesized
110                                              Pasteurella multocida toxin (PMT) is a potent mitogen fo
111                                              Pasteurella multocida toxin (PMT) is a potent mitogen kn
112                                          The Pasteurella multocida toxin (PMT) is a potent mitogen wh
113                        The results show that Pasteurella multocida toxin (PMT) significantly enhanced
114 atalytic and receptor-binding domains of the Pasteurella multocida toxin (PMT) were investigated.
115 not obvious and is explored with recombinant Pasteurella multocida toxin (rPMT, a Galpha(q) agonist).
116 ion on its own, it potentiated the effect of Pasteurella multocida toxin by 2-fold and ionomycin by 3
117                                          The Pasteurella multocida toxin was utilized as a unique too
118 quires protein kinase C and MEK activity) by Pasteurella multocida toxin, a Galpha(q) agonist that pr
119 er these conditions, treatment of cells with Pasteurella multocida toxin, a selective inhibitor of Ga
120 channel current inhibition was diminished by Pasteurella multocida toxin, mimicked by constitutively
121                                These include Pasteurella multocida toxin, which uniquely acts as a mi
122 ogous to the membrane targeting C1 domain of Pasteurella multocida toxin.
123 otein ChaN, and an uncharacterized domain of Pasteurella multocida toxin.
124 des tryptophanase; as well as a homologue of Pasteurella multocida tsaA, which encodes an alkyl perox
125 in a single polypeptide as was found for the Pasteurella multocida Type A PmHAS, the hyaluronan synth
126            Heparosan synthase 1 (PmHS1) from Pasteurella multocida Type D is a dual action glycosyltr
127                                              Pasteurella multocida Type D, a causative agent of atrop
128 noculated intranasally with 9 x 10(7) CFU of Pasteurella multocida type D.
129                                              Pasteurella multocida Type F, the minor fowl cholera pat
130 The extracellular polysaccharide capsules of Pasteurella multocida types A, D, and F are composed of
131 ue of the NeuA C-terminal domain (Pm1710) in Pasteurella multocida was also shown to be an esterase,
132                                              Pasteurella multocida was grown in iron-free chemically
133 ytica and three matched pairs of isolates of Pasteurella multocida were isolated by using a nasal swa
134   The major outer membrane protein (OmpH) of Pasteurella multocida X-73 was purified by selective ext
135                                       Type A Pasteurella multocida, a prevalent animal pathogen, empl
136 l pathogens, including Haemophilus parasuis, Pasteurella multocida, Actinobacillus pleuropneumoniae,
137  Synechocystis sp., Deinococcus radiodurans, Pasteurella multocida, and Actinobacillus actinomycetemc
138 ose of Salmonella enterica, Vibrio cholerae, Pasteurella multocida, and Haemophilus influenzae.
139 isease is caused by Gram-negative bacterium, Pasteurella multocida, and is considered to be endemic i
140 l systems, including Pseudomonas aeruginosa, Pasteurella multocida, and Legionella spp.
141            Fowl cholera, a disease caused by Pasteurella multocida, continues to be a major problem f
142 tein, PfhB2, from the opportunistic pathogen Pasteurella multocida, in our analysis.
143       Avian cholera, caused by the bacterium Pasteurella multocida, is a common and important infecti
144  bacteria, including Haemophilus influenzae, Pasteurella multocida, Neisseria gonorrhoeae, Neisseria
145 se of rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculatio
146 e genome sequence of a common avian clone of Pasteurella multocida, Pm70.
147 an synthases from the Gram-negative bacteria Pasteurella multocida, PmHS1 and PmHS2, were efficiently
148 tive causative agent of Saiga mass die-offs, Pasteurella multocida, was not detected in the Saiga mic
149 5 from Haemophilus influenzae and Oma87 from Pasteurella multocida.
150 nia pestis and the human and animal pathogen Pasteurella multocida.
151 tion of the pig's upper respiratory tract by Pasteurella multocida.
152 ely related species, Actinobacillus suis and Pasteurella multocida.
153 gaard taxon 45, an unnamed close relative of Pasteurella multocida.
154  7) with Actinobacillus pleuropneumoniae and Pasteurella multocida.
155 ia meningitidis, Haemophilus influenzae, and Pasteurella multocida.
156 ilus influenzae, Neisseria meningitidis, and Pasteurella multocida.
157 acteria including Haemophilus influenzae and Pasteurella multocida.
158 Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida.
159 the second most common site of infection for PASTEURELLA: Of the more than 17 species of Pasteurella
160       The 35K and 32K major OMPs, designated Pasteurella outer membrane proteins A and B (PomA and Po
161 induced periodontitis ( n = 6-7/group) where Pasteurella pneumotropica ( Pp)-reactive immune response
162  from Defluviimonas sp.20V17 and PpCas9 from Pasteurella pneumotropica.
163 ally infected by the opportunistic bacterium Pasteurella pneumotropica.
164 ined putative virulence factors, including a Pasteurella-related bacterium that had previously been l
165 plex microbiologic mix that usually includes pasteurella species but may also include many other orga
166 lity testing were performed on 73 strains of Pasteurella species isolated from human infections and o
167                                              Pasteurella species were the most frequent isolates from
168  susceptible to opportunistically pathogenic Pasteurella species.
169 ear reliable for testing susceptibilities of Pasteurella species.
170  American Type Culture Collection strains of Pasteurella species.
171 ences of the D15-related proteins from other Pasteurella spp.
172               Two and 17 cattle nasally shed Pasteurella spp. before and after transport, respectivel
173 espiratory tract infections with viruses and Pasteurella spp. were determined sequentially among 26 c
174 ive of the 26 lung samples were positive for Pasteurella spp., and their CFU ranged between 4.0 x 10(
175 ed microbial clades spanning Actinobacillus, Pasteurella, Streptococcus, and Erysipelothrix.
176 longs to the HAP (Haemophilus-Actinobacillus-Pasteurella) theta replicon family.
177 ) haemolytica, 6 Mannheimia glucosida, and 4 Pasteurella trehalosi strains by comparative nucleotide
178 ) haemolytica, 6 Mannheimia glucosida, and 4 Pasteurella trehalosi strains.
179 two related species Mannheimia glucosida and Pasteurella trehalosi, and four contain recombinant segm
180 cal Subject Headings Francisella tularensis, Pasteurella tularensis, biological weapon, biological te

 
Page Top